Dismissal Of Securities Class Action Against Drug Maker Overturned

Mealey's (October 12, 2018, 1:48 PM EDT) -- CINCINNATI — A Sixth Circuit U.S. Court of Appeals panel on Sept. 27 ruled that a federal district court erred in dismissing a shareholder class action against a drug company and...
To view the full article, register now.